Search results
Results from the WOW.Com Content Network
Contrast CT of a patient with brain metastases from breast cancer, before (left) and after (right) injection of iodinated contrast.. Iodinated contrast is a form of water-soluble, intravenous radiocontrast agent containing iodine, which enhances the visibility of vascular structures and organs during radiographic procedures.
However, there are no absolute contraindications to iodinated contrast, so the benefits needs to be weighted against the risks. [14] As with CT scans in general, the radiation dose can potentially increase the risk of radiation-induced cancer. The injection of iodinated contrast agents may sometimes lead to its extravasation. [15]
The World Health Organization issued a restriction on use of several gadolinium contrast agents in November 2009 stating that "High-risk gadolinium-containing contrast agents (Optimark, Omniscan, Magnevist, Magnegita, and Gado-MRT ratiopharm) are contraindicated in patients with severe kidney problems, in patients who are scheduled for or have ...
Drug interactions are similar to other iodine-containing contrast agents. Iodine-131 , a radioactive isotope used for thyroid imaging ( scintigraphy ) and therapy of thyroid cancers , can be less effective when used within two to six weeks after application of iotrolan because of residual iodine in the body.
An intravenous pyelogram is used to look for problems relating to the urinary tract. [5] These may include blockages or narrowing, such as due to kidney stones, cancer (such as renal cell carcinoma or transitional cell carcinoma), enlarged prostate glands, and anatomical variations, [5] such as a medullary sponge kidney. [6]
A high osmolar contrast agent such as diatrizoate or a low osmolar contrast agent such as Iotalamic acid with a concentration of 150 mg per ml is used for the procedure. [2] [1] The urinary bladder is catheterised under aseptic technique. The contrast medium is slowly injected or dripped in.
Contrast-enhanced ultrasound is regarded as safe in adults, comparable to the safety of MRI contrast agents, and better than radiocontrast agents used in contrast CT scans. The more limited safety data in children suggests that such use is as safe as in the adult population.
European guidelines classify a pre-existing decreased kidney function to be a risk factor of contrast-induced nephropathy in the following cases: [5]. Estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73 m 2 of body surface area before intra-arterial administration with first-pass renal exposure (not passing lungs or peripheral circulation before kidneys), or in the intensive care unit